Author: Gábor Cserni
View More View Less
  • 1 Bács-Kiskun Megyei Kórház Patológiai Osztály Kecskemét Nyíri út 49. 6000
  • | 2 Szegedi Tudományegyetem, Általános Orvostudományi Kar Patológiai Intézet Szeged Állomás u. 2. 6725
Restricted access

Az axillaris blokkdissectio emlőrákos betegeknél tradicionálisan egy terápiás és stádiummeghatározó műtét, amely során a hónalji nyirokcsomókat szelektivitás nélkül távolítják el. A mai napig ellentmondásos annak a megítélése, hogy a hónalji nyirokcsomók eltávolításának van-e túlélést befolyásoló szerepe. Az őrszemnyirokcsomó-biopszia során a regionális áttétek legvalószínűbb helyét, a primer tumorral direkt összeköttetésben álló nyirokcsomókat távolítják el, ami lehetőséget ad részletesebb stagingvizsgálatokra, és lehetővé teszi a hónalji blokkdissectio szelektívvé tételét, azon betegeknél indikálva azt, akiknél úgy véljük, ennek haszna lehet. Kezdetben a tanulási fázis alatt minden betegnél, majd csak az őrszemnyirokcsomóban áttétes betegeknél végeztek blokkdissectiót, de újabban bizonyos körülmények között, minimális érintettség mellett akár őrszemnyirokcsomó-makrometasztázisok esetén is biztonságosnak tartják a blokkdissectio elhagyását. Jelen közlemény a hónalj sebészi kezelésének változásait, az ezek mögött álló evidenciákat és ellentmondásokat, valamint az ezekkel kapcsolatos ajánlásokat foglalja össze. Orv. Hetil., 2014, 155(6), 203–215.

  • Cserni, G.: The sentinel lymph node theory in breast cancer. [Az őrszemnyirokcsomók elmélete emlőrákban.] Magyar Tudomány, 2004, 7, 718–722. [Hungarian]

    Cserni G. , 'The sentinel lymph node theory in breast cancer. [Az őrszemnyirokcsomók elmélete emlőrákban.] ' (2004 ) 7 Magyar Tudomány : 718 -722.

    • Search Google Scholar
  • Lyman, G. H., Giuliano, A. E., Somerfield, M. R., et al.: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J. Clin. Oncol., 2005, 23, 7703–7720.

    Somerfield M. R. , 'American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer ' (2005 ) 23 J. Clin. Oncol. : 7703 -7720.

    • Search Google Scholar
  • Zarebczan Dull, B., Neuman, H. B.: Management of the axilla. Surg. Clin. North. Am., 2013, 93, 429–444.

    Neuman H. B. , 'Management of the axilla ' (2013 ) 93 Surg. Clin. North. Am. : 429 -444.

  • Tabár, L., Duffy, S. W., Vitak, B., et al.: The natural history of breast carcinoma: what have we learned from screening? Cancer, 1999, 86, 449–462.

    Vitak B. , 'The natural history of breast carcinoma: what have we learned from screening? ' (1999 ) 86 Cancer : 449 -462.

    • Search Google Scholar
  • Cady, B., Stone, M. D., Schuler, J. G., et al.: The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch. Surg., 1996, 131, 301–308.

    Schuler J. G. , 'The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening ' (1996 ) 131 Arch. Surg. : 301 -308.

    • Search Google Scholar
  • Orr, R. K.: The impact of prophylactic axillary node dissection on breast cancer survival – a Bayesian meta-analysis. Ann. Surg. Oncol., 1999, 6, 109–116.

    Orr R. K. , 'The impact of prophylactic axillary node dissection on breast cancer survival – a Bayesian meta-analysis ' (1999 ) 6 Ann. Surg. Oncol. : 109 -116.

    • Search Google Scholar
  • Sanghani, M., Balk, E. M., Cady, B.: Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients. Cancer, 2009, 115, 1613–1620.

    Cady B. , 'Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients ' (2009 ) 115 Cancer : 1613 -1620.

    • Search Google Scholar
  • Clarke, M., Collins, R., Darby, S., et al.: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet, 2005, 366, 2087–2106.

    Darby S. , 'Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials ' (2005 ) 366 Lancet : 2087 -2106.

    • Search Google Scholar
  • Krag, D. N., Weaver, D. L., Alex, J. C., et al.: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol., 1993, 2, 335–340.

    Alex J. C. , 'Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe ' (1993 ) 2 Surg. Oncol. : 335 -340.

    • Search Google Scholar
  • Giuliano, A. E., Kirgan, D. M., Guenther, J. M., et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann. Surg., 1994, 220, 391–401.

    Guenther J. M. , 'Lymphatic mapping and sentinel lymphadenectomy for breast cancer ' (1994 ) 220 Ann. Surg. : 391 -401.

    • Search Google Scholar
  • Cserni, G., Boross, G., Baltás, B.: The role of the histopathological analysis of sentinel lymph nodes in breast cancer. Preliminary findings. [Az őrszem (sentinel) -nyirokcsomó szövettani vizsgálatának jelentősége emlőrákban. Első tapasztalatok.] Orv. Hetil., 1998, 139, 1899–1903. [Hungarian]

    Baltás B. , 'The role of the histopathological analysis of sentinel lymph nodes in breast cancer. Preliminary findings. [Az őrszem (sentinel) -nyirokcsomó szövettani vizsgálatának jelentősége emlőrákban. Első tapasztalatok.] ' (1998 ) 139 Orv. Hetil. : 1899 -1903.

    • Search Google Scholar
  • Boross, G., Cserni, G., Baltás, B.: The significance of sentinel lymph node surgery in breast cancer. First experiences. [A sentinel nyirokcsomó sebészeti jelentősége emlőrákban – Első tapasztalatok.] Magyar Sebészet, 1999, 52, 4–6. [Hungarian]

    Baltás B. , 'The significance of sentinel lymph node surgery in breast cancer. First experiences. [A sentinel nyirokcsomó sebészeti jelentősége emlőrákban – Első tapasztalatok.] ' (1999 ) 52 Magyar Sebészet : 4 -6.

    • Search Google Scholar
  • Giuliano, A. E., Dale, P. S., Turner, R. R., et al.: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann. Surg., 1995, 222, 394–401.

    Turner R. R. , 'Improved axillary staging of breast cancer with sentinel lymphadenectomy ' (1995 ) 222 Ann. Surg. : 394 -401.

    • Search Google Scholar
  • Anninga, B., Ahmed, M., Van Hemelrijck, M., et al.: Magnetic sentinel lymph node biopsy and localization properties of a magnetic tracer in an in vivo porcine model. Breast Cancer Res. Treat., 2013, 141, 33–42.

    Hemelrijck M. , 'Magnetic sentinel lymph node biopsy and localization properties of a magnetic tracer in an in vivo porcine model ' (2013 ) 141 Breast Cancer Res. Treat. : 33 -42.

    • Search Google Scholar
  • Pesek, S., Ashikaga, T., Krag, L. E., et al.: The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis. World J. Surg., 2012, 36, 2239–2251.

    Krag L. E. , 'The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis ' (2012 ) 36 World J. Surg. : 2239 -2251.

    • Search Google Scholar
  • Veronesi, U., Viale, G., Paganelli, G., et al.: Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann. Surg., 2010, 251, 595–600.

    Paganelli G. , 'Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study ' (2010 ) 251 Ann. Surg. : 595 -600.

    • Search Google Scholar
  • Zavagno, G., De Salvo, G. L., Scalco, G., et al.: A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM Trial. Ann. Surg., 2008, 247, 207–213.

    Scalco G. , 'A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM Trial ' (2008 ) 247 Ann. Surg. : 207 -213.

    • Search Google Scholar
  • Andersson, Y., de Boniface, J., Jönsson, P. E., et al.: Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer. Br. J. Surg., 2012, 99, 226–231.

    Jönsson P. E. , 'Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer ' (2012 ) 99 Br. J. Surg. : 226 -231.

    • Search Google Scholar
  • Hunt, K. K., Ballman, K. V., McCall, L. M., et al.: Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial. Ann. Surg., 2012, 256, 428–436.

    McCall L. M. , 'Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial ' (2012 ) 256 Ann. Surg. : 428 -436.

    • Search Google Scholar
  • Krag, D. N., Anderson, S. J., Julian, T. B., et al.: Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol., 2010, 11, 927–933.

    Julian T. B. , 'Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial ' (2010 ) 11 Lancet Oncol. : 927 -933.

    • Search Google Scholar
  • Edge, S. B., Byrd, D. R., Compton, C. C., et al. (eds.): AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual. Springer, New York, 2010.

    '', in AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual , (2010 ) -.

  • Clarke, D., Newcombe, R. G., Mansel, R. E., et al.: The learning curve in sentinel node biopsy: the ALMANAC experience. Ann. Surg. Oncol., 2004, 11 (3 Suppl.), 211S–215S.

    Mansel R. E. , 'The learning curve in sentinel node biopsy: the ALMANAC experience ' (2004 ) 11 Ann. Surg. Oncol. : 211S -215S.

    • Search Google Scholar
  • Mansel, R. E., MacNeill, F., Horgan, K., et al.: Results of a national training programme in sentinel lymph node biopsy for breast cancer. Br. J. Surg., 2013, 100, 654–661.

    Horgan K. , 'Results of a national training programme in sentinel lymph node biopsy for breast cancer ' (2013 ) 100 Br. J. Surg. : 654 -661.

    • Search Google Scholar
  • Mansel, R. E., Fallowfield, L., Kissin, M., et al.: Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J. Natl. Cancer Inst., 2006, 98, 599–609.

    Kissin M. , 'Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial ' (2006 ) 98 J. Natl. Cancer Inst. : 599 -609.

    • Search Google Scholar
  • Gill, G.: Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann. Surg. Oncol., 2009, 16, 266–275.

    Gill G. , 'Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial ' (2009 ) 16 Ann. Surg. Oncol. : 266 -275.

    • Search Google Scholar
  • Cserni, G., Kulka, J.: New TNM classification of breast tumors. [Az emlőrákok új TNM-klasszifikációja.] Orv. Hetil., 2003, 144, 1563–1568. [Hungarian]

    Kulka J. , 'New TNM classification of breast tumors. [Az emlőrákok új TNM-klasszifikációja.] ' (2003 ) 144 Orv. Hetil. : 1563 -1568.

    • Search Google Scholar
  • Cserni, G., Bianchi, S., Boecker, W., et al.: Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer, 2005, 103, 358–367.

    Boecker W. , 'Improving the reproducibility of diagnosing micrometastases and isolated tumor cells ' (2005 ) 103 Cancer : 358 -367.

    • Search Google Scholar
  • De Mascarel, I., MacGrogan, G., Debled, M., et al.: Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful? Cancer, 2008, 112, 1672–1678.

    Debled M. , 'Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful? ' (2008 ) 112 Cancer : 1672 -1678.

    • Search Google Scholar
  • Turner, R. R., Weaver, D. L., Cserni, G., et al.: Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. J. Clin. Oncol., 2008, 26, 258–263.

    Cserni G. , 'Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training ' (2008 ) 26 J. Clin. Oncol. : 258 -263.

    • Search Google Scholar
  • Cserni, G., Bianchi, S., Vezzosi, V., et al.: Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur. J. Cancer, 2008, 44, 2185–2191.

    Vezzosi V. , 'Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions ' (2008 ) 44 Eur. J. Cancer : 2185 -2191.

    • Search Google Scholar
  • Cserni, G., Amendoeira, I., Bianchi, S., et al.: Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitions. Eur. J. Cancer, 2011, 47, 887–894.

    Bianchi S. , 'Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitions ' (2011 ) 47 Eur. J. Cancer : 887 -894.

    • Search Google Scholar
  • Cserni, G., Gregori, D., Merletti, F., et al.: Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br. J. Surg., 2004, 91, 1245–1252.

    Merletti F. , 'Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer ' (2004 ) 91 Br. J. Surg. : 1245 -1252.

    • Search Google Scholar
  • Van Deurzen, C. H., de Boer, M., Monninkhof, E. M., et al.: Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J. Natl. Cancer Inst., 2008, 100, 1574–1580.

    Monninkhof E. M. , 'Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node ' (2008 ) 100 J. Natl. Cancer Inst. : 1574 -1580.

    • Search Google Scholar
  • Giuliano, A. E., McCall, L., Beitsch, P., et al.: Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann. Surg., 2010, 252, 426–432.

    Beitsch P. , 'Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial ' (2010 ) 252 Ann. Surg. : 426 -432.

    • Search Google Scholar
  • Solá, M., Alberro, J. A., Fraile, M., et al.: Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000. Ann. Surg. Oncol., 2013, 20, 120–127.

    Fraile M. , 'Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000 ' (2013 ) 20 Ann. Surg. Oncol. : 120 -127.

    • Search Google Scholar
  • Galimberti, V., Cole, B. F., Zurrida, S., et al.: Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol., 2013, 14, 297–305.

    Zurrida S. , 'Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial ' (2013 ) 14 Lancet Oncol. : 297 -305.

    • Search Google Scholar
  • Fisher, B., Jeong, J. H., Anderson, S., et al.: Twenty-five year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N. Engl. J. Med., 2002, 347, 567–575.

    Anderson S. , 'Twenty-five year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation ' (2002 ) 347 N. Engl. J. Med. : 567 -575.

    • Search Google Scholar
  • Goldhirsch, A., Glick, J. H., Gelber, R. D., et al.: Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann. Oncol., 2005, 16, 1569–1583.

    Gelber R. D. , 'Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005 ' (2005 ) 16 Ann. Oncol. : 1569 -1583.

    • Search Google Scholar
  • Goldhirsch, A., Wood, W. C., Coates, A. S., et al.: Strategies for subtypes – dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann. Oncol., 2011, 22, 1736–1747.

    Coates A. S. , 'Strategies for subtypes – dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 ' (2011 ) 22 Ann. Oncol. : 1736 -1747.

    • Search Google Scholar
  • AGO, DGS, SGS, ÖGS, Panelists, Executive Board Members: German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer. Eur. J. Cancer, 2013, 49, 2277–2283.

    'German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer ' (2013 ) 49 Eur. J. Cancer : 2277 -2283.

    • Search Google Scholar
  • Kaufmann, M., Morrow, M., von Minckwitz, G., et al.: Locoregional treatment of primary breast cancer. Consensus recommendations from an international expert panel. Cancer, 2010, 116, 1184–1191.

    Minckwitz G. , 'Locoregional treatment of primary breast cancer. Consensus recommendations from an international expert panel ' (2010 ) 116 Cancer : 1184 -1191.

    • Search Google Scholar
  • Tvedskov, T. F., Jensen, M. B., Lisse, I. M., et al.: High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node. Int. J. Cancer, 2012, 131, 2367–2375.

    Lisse I. M. , 'High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node ' (2012 ) 131 Int. J. Cancer : 2367 -2375.

    • Search Google Scholar
  • Meretoja, T. J., Strien, L., Heikkilä, P. S., et al.: A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement. Ann. Surg. Oncol., 2012, 19, 567–576.

    Heikkilä P. S. , 'A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement ' (2012 ) 19 Ann. Surg. Oncol. : 567 -576.

    • Search Google Scholar
  • Houvenaeghel, G., Nos, C., Giard, S., et al.: A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur. J. Surg. Oncol., 2009, 35, 690–695.

    Giard S. , 'A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis ' (2009 ) 35 Eur. J. Surg. Oncol. : 690 -695.

    • Search Google Scholar
  • Van la Parra, R. F., Peer, P. G., Ernst, M. F., et al.: Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN. Eur. J. Surg. Oncol., 2011, 37, 290–299.

    Ernst M. F. , 'Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN ' (2011 ) 37 Eur. J. Surg. Oncol. : 290 -299.

    • Search Google Scholar
  • Cserni, G.: Sentinel node biopsy and nodal staging. In: Breast cancer, a heterogeneous disease entity. The very early stages. Eds.: Kahán, Zs., Tot, T. Springer Science+Business Media BV, Dordrecht-Heidelberg-London-New York, 2011, 149–184.

    Cserni G. , '', in Breast cancer, a heterogeneous disease entity. The very early stages , (2011 ) -.

  • Cserni, G., Bori, R., Sejben, I., et al.: Analysis of predictive tools for further axillary involvement in patients with sentinel-lymph-node-positive, small (< or =15 mm) invasive breast cancer. [A hónalji nyirokcsomók további érintettségére vonatkozó modellek elemzése kisméretű (≤15 mm) őrszemnyirokcsomó-áttétes emlőrákokban.] Orv. Hetil., 2009, 150, 2182–2188. [Hungarian]

    Sejben I. , 'Analysis of predictive tools for further axillary involvement in patients with sentinel-lymph-node-positive, small (< or =15 mm) invasive breast cancer. [A hónalji nyirokcsomók további érintettségére vonatkozó modellek elemzése kisméretű (≤15 mm) őrszemnyirokcsomó-áttétes emlőrákokban.] ' (2009 ) 150 Orv. Hetil. : 2182 -2188.

    • Search Google Scholar
  • Cserni, G., Bezsenyi, I., Markó, L.: Patients’ choice on axillary lymph node dissection following sentinel lymph node micrometastasis – First report on prospective use of a nomogram in very low risk patients. Pathol. Oncol. Res., 2013, 19, 211–216.

    Markó L. , 'Patients’ choice on axillary lymph node dissection following sentinel lymph node micrometastasis – First report on prospective use of a nomogram in very low risk patients ' (2013 ) 19 Pathol. Oncol. Res. : 211 -216.

    • Search Google Scholar
  • Sávolt, A., Polgár, Cs., Musonda, P., et al.: Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients? Clin. Breast Cancer, 2013, 13, 364–370.

    Musonda P. , 'Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients? ' (2013 ) 13 Clin. Breast Cancer : 364 -370.

    • Search Google Scholar
  • Rutgers, E. J., Donker, M., Straver, M. E., et al.: Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial (10981/22023). J. Clin. Oncol., 2013, 31 (Suppl), abstract LBA1001.

    Straver M. E. , 'Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: Final analysis of the EORTC AMAROS trial (10981/22023) ' (2013 ) 31 J. Clin. Oncol. : -.

    • Search Google Scholar
  • Straver, M. E., Meijnen, P., van Tienhoven, G., et al.: Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann. Surg. Oncol., 2010, 17, 1854–1861.

    Tienhoven G. , 'Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial ' (2010 ) 17 Ann. Surg. Oncol. : 1854 -1861.

    • Search Google Scholar
  • Lucci, A., McCall, L. M., Beitsch, P. D., et al.: Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J. Clin. Oncol., 2007, 25, 3657–3663.

    Beitsch P. D. , 'Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011 ' (2007 ) 25 J. Clin. Oncol. : 3657 -3663.

    • Search Google Scholar
  • Bilimoria, K. Y., Bentrem, D. J., Hansen, N. M., et al.: Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J. Clin. Oncol., 2009, 27, 2946–2953.

    Hansen N. M. , 'Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer ' (2009 ) 27 J. Clin. Oncol. : 2946 -2953.

    • Search Google Scholar
  • Caudle, A. S., Hunt, K. K., Tucker, S. L., et al.: American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns. Ann. Surg. Oncol., 2012, 19, 3144–3151.

    Tucker S. L. , 'American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns ' (2012 ) 19 Ann. Surg. Oncol. : 3144 -3151.

    • Search Google Scholar
  • Cody, H. S. 3rd., Houssami, N.: Axillary management in breast cancer: What’s new for 2012? Breast, 2012, 21, 411–415.

    Houssami N. , 'Axillary management in breast cancer: What’s new for 2012? ' (2012 ) 21 Breast : 411 -415.

    • Search Google Scholar
  • Goldhirsch, A., Winer, E. P., Coates, A. S., et al.: Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann. Oncol., 2013, 24, 2206–2223.

    Coates A. S. , 'Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 ' (2013 ) 24 Ann. Oncol. : 2206 -2223.

    • Search Google Scholar
  • Gatzemeier, W., Mann, G. B.: Which sentinel-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND) – ACOSOG Z0011 results and beyond. Breast, 2013, 22, 211–216.

    Mann G. B. , 'Which sentinel-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND) – ACOSOG Z0011 results and beyond ' (2013 ) 22 Breast : 211 -216.

    • Search Google Scholar
  • Giuliano, A. E.: Reply to letter: Are the standard tangential breast irradiation fields used in the ACOSOG Z0011 trial really covering the entire axilla? Ann. Surg., 2013, 257, e2.

    Giuliano A. E. , 'Reply to letter: Are the standard tangential breast irradiation fields used in the ACOSOG Z0011 trial really covering the entire axilla? ' (2013 ) 257 Ann. Surg. : e2 -.

    • Search Google Scholar
  • Ainsworth, R. K., Kollias, J., Le Blanc, A., et al.: The clinical impact of the American College of Surgeons Oncology Group Z-0011 trial – results from the BreastSurgANZ National Breast Cancer Audit. Breast, 2013, 22, 733–735.

    Blanc A. , 'The clinical impact of the American College of Surgeons Oncology Group Z-0011 trial – results from the BreastSurgANZ National Breast Cancer Audit ' (2013 ) 22 Breast : 733 -735.

    • Search Google Scholar
  • Caretta-Weyer, H., Greenberg, C. G., Wilke, L. G., et al.: Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on Clinical Management of the Axilla in Older Breast Cancer Patients: A SEER-Medicare Analysis. Ann. Surg. Oncol., 2013, 20, 4145–4152.

    Wilke L. G. , 'Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on Clinical Management of the Axilla in Older Breast Cancer Patients: A SEER-Medicare Analysis ' (2013 ) 20 Ann. Surg. Oncol. : 4145 -4152.

    • Search Google Scholar
  • Güth, U., Myrick, M. E., Viehl, C. T., et al.: The post ACOSOG Z0011 era: does our new understanding of breast cancer really change clinical practice? Eur. J. Surg. Oncol., 2012, 38, 645–650.

    Viehl C. T. , 'The post ACOSOG Z0011 era: does our new understanding of breast cancer really change clinical practice? ' (2012 ) 38 Eur. J. Surg. Oncol. : 645 -650.

    • Search Google Scholar
  • Dengel, L. T., Van Zee, K. J., King, T. A., et al.: Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy.; Ann. Surg. Oncol., 2013 Aug 22. [Epub ahead of print]

  • Delpech, Y., Bricou, A., Lousquy, R., et al.: The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study. Ann. Surg. Oncol., 2013, 20, 2556–2561.

    Lousquy R. , 'The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study ' (2013 ) 20 Ann. Surg. Oncol. : 2556 -2561.

    • Search Google Scholar
  • Cserni, G., Bori, R., Maráz, R., et al.: Multi-institutional comparison of non-sentinel lymph node predictive tools in breast cancer patients with high predicted risk of further axillary metastasis. Pathol. Oncol. Res., 2013, 19, 95–101.

    Maráz R. , 'Multi-institutional comparison of non-sentinel lymph node predictive tools in breast cancer patients with high predicted risk of further axillary metastasis ' (2013 ) 19 Pathol. Oncol. Res. : 95 -101.

    • Search Google Scholar
  • Meretoja, T. J., Audisio, R. A. A., Heikkilä, P., et al.: International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases. Breast Cancer Res. Treat., 2013, 138, 817–827.

    Heikkilä P. , 'International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases ' (2013 ) 138 Breast Cancer Res. Treat. : 817 -827.

    • Search Google Scholar
  • Rudenstam, C. M., Zahrieh, D., Forbes, J. F., et al.: Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J. Clin. Oncol., 2006, 24, 337–344.

    Forbes J. F. , 'Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93 ' (2006 ) 24 J. Clin. Oncol. : 337 -344.

    • Search Google Scholar
  • Wyld, L., Reed, M.: The role of surgery in the management of older women with breast cancer. Eur. J. Cancer, 2007, 43, 2253–2263.

    Reed M. , 'The role of surgery in the management of older women with breast cancer ' (2007 ) 43 Eur. J. Cancer : 2253 -2263.

    • Search Google Scholar
  • Martelli, G., Boracchi, P., Ardoino, I., et al.: Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial. Ann. Surg., 2012, 256, 920–924.

    Ardoino I. , 'Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial ' (2012 ) 256 Ann. Surg. : 920 -924.

    • Search Google Scholar
  • National Comprehensive Cancer Network: Clinical practice guidelines in oncology – Breast cancer v3.2 2013. Available from: http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf; (2013 October 25.)

  • Chung, M. H., Ye, W., Giuliano, A. E.: Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann. Surg. Oncol., 2001, 8, 688–692.

    Giuliano A. E. , 'Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer ' (2001 ) 8 Ann. Surg. Oncol. : 688 -692.

    • Search Google Scholar
  • Wong, S. L., Chao, C., Edwards, M. J., et al.: Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers. Am. Surg., 2001, 67, 522–526.

    Edwards M. J. , 'Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers ' (2001 ) 67 Am. Surg. : 522 -526.

    • Search Google Scholar
  • Specht, M. C., Fey, J. V., Borgen, P. I., et al.: Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J. Am. Coll. Surg., 2005, 200, 10–14.

    Borgen P. I. , 'Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? ' (2005 ) 200 J. Am. Coll. Surg. : 10 -14.

    • Search Google Scholar
  • Van Deurzen, C. H., Vriens, B. E., Tjan-Heijnen, V. C., et al.: Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur. J. Cancer, 2009, 45, 3124–3130.

    Tjan-Heijnen V. C. , 'Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review ' (2009 ) 45 Eur. J. Cancer : 3124 -3130.

    • Search Google Scholar
  • Tan, V. K., Goh, B. K., Fook-Chong, S., et al.: The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer – a systematic review and meta-analysis. J. Surg. Oncol., 2011, 104, 97–103.

    Fook-Chong S. , 'The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer – a systematic review and meta-analysis ' (2011 ) 104 J. Surg. Oncol. : 97 -103.

    • Search Google Scholar
  • Boughey, J. C., Suman, V. J., Mittendorf, E. A., et al.: Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA, 2013, 310, 1455–1461.

    Mittendorf E. A. , 'Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial ' (2013 ) 310 JAMA : 1455 -1461.

    • Search Google Scholar
  • Kuehn, T., Bauerfeind, I., Fehm, T., et al.: Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol., 2013, 14, 609–618.

    Fehm T. , 'Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study ' (2013 ) 14 Lancet Oncol. : 609 -618.

    • Search Google Scholar
  • Ansari, B., Ogston, S. A., Purdie, C. A., et al.: Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br. J. Surg., 2008, 95, 547–554.

    Purdie C. A. , 'Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast ' (2008 ) 95 Br. J. Surg. : 547 -554.

    • Search Google Scholar
  • McMasters, K. M., Chao, C., Wong, S. L., et al.: Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal. Cancer, 2002, 95, 15–20.

    Wong S. L. , 'Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal ' (2002 ) 95 Cancer : 15 -20.

    • Search Google Scholar
  • Cserni, G., Boross, G., Maráz, R., et al.: Sentinel lymph node biopsy for in situ carcinoma of the breast. Experience at the Bács-Kiskun County Teaching Hospital and review of the literature. [Őrszemnyirokcsomó-biopszia in situ emlőrákban. A Bács-Kiskun Megyei Önkormányzat Kórházának tapasztalatai és irodalmi összefoglalás.] Magy. Seb., 2006, 59, 164–172. [Hungarian]

    Maráz R. , 'Sentinel lymph node biopsy for in situ carcinoma of the breast. Experience at the Bács-Kiskun County Teaching Hospital and review of the literature. [Őrszemnyirokcsomó-biopszia in situ emlőrákban. A Bács-Kiskun Megyei Önkormányzat Kórházának tapasztalatai és irodalmi összefoglalás.] ' (2006 ) 59 Magy. Seb. : 164 -172.

    • Search Google Scholar
  • Takács, T., Paszt, A., Szentpáli, K., et al.: Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer. Pathol. Oncol. Res., 2009, 15, 329–333.

    Szentpáli K. , 'Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer ' (2009 ) 15 Pathol. Oncol. Res. : 329 -333.

    • Search Google Scholar
  • Chin-Lenn, L., Mack, L. A., Temple, W., et al.: Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy. Ann. Surg. Oncol., 2013 Sep 18. [Epub ahead of print]

  • Deurloo, E. E., Tanis, P. J., Gilhuijs, K. G., et al.: Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur. J. Cancer, 2003, 39, 1068–1073.

    Gilhuijs K. G. , 'Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer ' (2003 ) 39 Eur. J. Cancer : 1068 -1073.

    • Search Google Scholar
  • Sapino, A., Cassoni, P., Zanon, E., et al.: Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br. J. Cancer, 2003, 88, 702–706.

    Zanon E. , 'Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management ' (2003 ) 88 Br. J. Cancer : 702 -706.

    • Search Google Scholar
  • Zgajnar, J., Besic, N., Podkrajsek, M., et al.: Minimal risk of macrometastases in the non-sentinel axillary lymph nodes in breast cancer patients with micrometastatic sentinel lymph nodes and preoperatively ultrasonically uninvolved axillary lymph nodes. Eur. J. Cancer, 2005, 41, 244–248.

    Podkrajsek M. , 'Minimal risk of macrometastases in the non-sentinel axillary lymph nodes in breast cancer patients with micrometastatic sentinel lymph nodes and preoperatively ultrasonically uninvolved axillary lymph nodes ' (2005 ) 41 Eur. J. Cancer : 244 -248.

    • Search Google Scholar
  • Gentilini, O., Veronesi, U.: Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). Breast, 2012, 21, 678–681.

    Veronesi U. , 'Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND) ' (2012 ) 21 Breast : 678 -681.

    • Search Google Scholar
  • Lovrics, P. J., Chen, V., Coates, G., et al.: A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Ann. Surg. Oncol., 2004, 11, 846–853.

    Coates G. , 'A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer ' (2004 ) 11 Ann. Surg. Oncol. : 846 -853.

    • Search Google Scholar
  • Vernonesi, U., De Cicco, C., Galimberti, V. E., et al.: A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann. Oncol., 2007, 18, 473–478.

    Galimberti V. E. , 'A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases ' (2007 ) 18 Ann. Oncol. : 473 -478.

    • Search Google Scholar
  • Robertson, I. J., Hand, F., Kell, M. R.: FDG-PET/CT in the staging of local/regional metastases in breast cancer. Breast, 2011, 20, 491–494.

    Kell M. R. , 'FDG-PET/CT in the staging of local/regional metastases in breast cancer ' (2011 ) 20 Breast : 491 -494.

    • Search Google Scholar
  • Pritchard, K. I., Julian, J. A., Holloway, C. M., et al.: Prospective study of 2-[18F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study. J. Clin. Oncol., 2012, 30, 1274–1279.

    Holloway C. M. , 'Prospective study of 2-[18F]fluorodeoxyglucose positron emission tomography in the assessment of regional nodal spread of disease in patients with breast cancer: an Ontario clinical oncology group study ' (2012 ) 30 J. Clin. Oncol. : 1274 -1279.

    • Search Google Scholar
  • Lázár, G., Besznyák, I., Boross, G., et al.: Current surgical therapy in breast cancer. [Az emlőrák korszerű sebészi kezelése.] Magy. Onkol., 2010, 54, 227–234. [Hungarian]

    Boross G. , 'Current surgical therapy in breast cancer. [Az emlőrák korszerű sebészi kezelése.] ' (2010 ) 54 Magy. Onkol. : 227 -234.

    • Search Google Scholar
The author instructions are available in PDF.
Instructions for Authors in Hungarian HERE.
Mendeley citation style is available HERE.

Főszerkesztő - Editor-in-Chief:
 
Zoltán PAPP (professor emeritus, Semmelweis Egyetem, Szülészeti és Nőgyógyászati Klinika, Budapest)

Read the professional career of Zoltán PAPP HERE.

All scientific publications of Zoltán PAPP are collected in the Hungarian Scientific Bibliography.

Főszerkesztő-helyettesek - Assistant Editors-in-Chief: 

  • Erzsébet FEHÉR (professor emeritus, Semmelweis Egyetem, Anatómiai, Szövet- és Fejlődéstani Intézet)
  • Krisztina HAGYMÁSI (egyetemi docens, Semmelweis Egyetem, I. Sebészeti és Intervenciós Gasztroenterológiai Klinika, Budapest)

Főmunkatársak - Senior Editorial Specialists:

  • László KISS (a Debreceni Egyetem habilitált doktora)
  • Gabriella LENGYEL (ny. egyetemi docens, Semmelweis Egyetem, I. Sebészeti és Intervenciós Gasztroenterológiai Klinika, Budapest)
  • Alajos PÁR (professor emeritus, Pécsi Tudományegyetem, I. Belgyógyászati Klinika)

 A Szerkesztőbizottság tagjai – Members of the Editorial Board:

  • Péter ANDRÉKA (főigazgató, Gottsegen György Országos Kardiovaszkuláris Intézet, Nemzeti Szívinfartkus Regiszter, Budapest)
  • Géza ÁCS Jr. (egyetemi tanár Floridában)
  • Csaba BALÁZS (egyetemi tanár, Budai Endokrinközpont, Budapest)
  • Péter BENCSIK (volt folyóirat-kiadás vezető, Akadémiai Kiadó, Budapest)
  • Zoltán BENYÓ (egyetemi tanár, Semmelweis Egyetem, Transzlációs Medicina Intézet, Budapest)
  • Dániel BERECZKI (egyetemi tanár, Semmelweis Egyetem, Neurológiai Klinika, Budapest)
  • Anna BLÁZOVICS (professor emeritus, Semmelweis Egyetem, Farmakognóziai Intézet, Budapest)
  • Elek DINYA (professor emeritus, biostatisztikus, Semmelweis Egyetem, Budapest)
  • Attila DOBOZY (professor emeritus, Szegedi Tudományegyetem, Bőrgyógyászati Klinika, Szeged)
  • András FALUS (professor emeritus, Semmelweis Egyetem, Genetikai, Sejt- és Immunbiológiai Intézet, Budapest)
  • Csaba FARSANG (egyetemi tanár, Szent Imre Oktató Kórház, Belgyógyászati Osztály, Budapest)
  • János FAZAKAS (egyetemi docens, Semmelweis Egyetem, Transzplantációs és Sebészeti Klinika, Budapest)
  • Béla FÜLESDI (egyetemi tanár, Debreceni Egyetem, Aneszteziológiai és Intenzív Terápiás Klinika, Debrecen)
  • Beáta GASZTONYI (egyetemi magántanár, kórházi főorvos, Zala Megyei Kórház, Belgyógyászat, Zalaegerszeg)
  • István GERGELY (egyetemi docens, Marosvásárhelyi Orvosi és Gyógyszerészeti Egyetem, Románia)
  • Judit GERVAIN (osztályvezető főorvos, Fejér Megyei Szent György Kórház, Belgyógyászat, Székesfehérvár)
  • Béla GÖMÖR (professor emeritus, Budai Irgalmasrendi Kórház, Reumatológiai Osztály, Budapest)
  • László GULÁCSI (egyetemi tanár, Óbudai Egyetem, Egészségügyi Közgazdaságtan Tanszék, Budapest)
  • János HANKISS (professor emeritus, Markusovszky Lajos Oktató Kórház, Belgyógyászati Osztály, Szombathely)
  • Örs Péter HORVÁTH (professor emeritus, Pécsi Tudományegyetem, Sebészeti Klinika, Pécs)
  • Béla HUNYADY (egyetemi tanár, Somogy Megyei Kaposi Mór Kórház, Belgyógyászat, Kaposvár)
  • Péter IGAZ (egyetemi tanár, Semmelweis Egyetem, Belgyógyászati és Onkológiai Klinika, Budapest)
  • Ferenc JAKAB (c. egyetemi tanár, Uzsoki Utcai Kórház, Sebészet, Budapest)
  • András JÁNOSI (c. egyetemi tanár, Gottsegen György Országos Kardiovaszkuláris Intézet, Nemzeti Szívinfartkus Regiszter, Budapest)
  • György JERMENDY (egyetemi tanár, Bajcsy-Zsilinszky Kórház, Belgyógyászat, Budapest)
  • László KALABAY (egyetemi tanár, Semmelweis Egyetem, Családorvosi Tanszék, Budapest)
  • János KAPPELMAYER (egyetemi tanár, Debreceni Egyetem, Laboratóriumi Medicina Intézet, Debrecen)
  • Éva KELLER (ny. egyetemi tanár, Semmelweis Egyetem, Igazságügyi és Biztosítás-orvostani Intézet, Budapest)
  • Mátyás KELTAI (ny. egyetemi docens, Gottsegen György Országos Kardiovaszkuláris Intézet, Nemzeti Szívinfartkus Regiszter, Budapest)
  • András KISS (egyetemi tanár, Semmelweis Egyetem, II. Patológiai Intézet, Budapest)
  • László KÓBORI (egyetemi tanár, Semmelweis Egyetem, Transzplantációs és Sebészeti Klinika, Budapest)
  • Lajos KULLMANN (ny. egyetemi tanár, Országos Rehabilitációs Intézet, Budapest)
  • Emese MEZŐSI (egyetemi tanár, Pécsi Tudományegyetem, I. Belgyógyászati Klinika, Pécs)
  • József MOLNÁR (professor emeritus, Szegedi Tudományegyetem, Mikrobiológiai és Immunológiai Intézet, Szeged)
  • Péter MOLNÁR (professor emeritus, Debreceni Egyetem, Magatartástudományi Intézet, Debrecen)
  • Györgyi MŰZES (egyetemi docens, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Bálint NAGY (egyetemi tanár, Debreceni Egyetem, Humángenetikai Tanszék, Debrecen)
  • Endre NAGY (egyetemi tanár, Debreceni Egyetem, Belgyógyászati Intézet, Debrecen) 
  • Péter NAGY (egyetemi tanár, Semmelweis Egyetem, I. Patológiai és Kísérleti Rákkutató Intézet, Budapest)
  • Viktor NAGY (főorvos, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Zoltán Zsolt NAGY (egyetemi tanár, Semmelweis Egyetem, Szemészeti Klinika, Budapest)
  • Balázs NEMES (egyetemi docens, Debreceni Egyetem, Transzplantációs Tanszék, Debrecen)
  • Attila PATÓCS (tudományos főmunkatárs, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Gabriella PÁR (egyetemi docens, Pécsi Tudományegyetem, I. Belgyógyászati Klinika)
  • György PFLIEGLER (egyetemi tanár, Debreceni Egyetem, Ritka Betegségek Tanszéke, Debrecen)
  • István RÁCZ (egyetemi tanár, főorvos, Petz Aladár Megyei Oktató Kórház, Belgyógyászat, Győr)
  • Imre ROMICS (professor emeritus, Semmelweis Egyetem, Urológiai Klinika, Budapest)
  • László Jr. ROMICS (Angliában dolgozik) 
  • Imre RURIK (egyetemi tanár, Debreceni Egyetem, Családorvosi és Foglalkozás-egészségügyi Tanszék, Debrecen)
  • Zsuzsa SCHAFF (professor emeritus, Semmelweis Egyetem, II. Patológiai Intézet, Budapest)
  • Péter SCHMIDT (házi gyermekorvos, Győr)
  • Kornél SIMON (ny. osztályvezető főorvos, Siófoki Kórház, Belgyógyászat, Siófok)
  • Gábor SIMONYI (vezető főorvos, Szent Imre Kórház, Anyagcsere Központ, Budapest)
  • Gábor Márk SOMFAI (egyetemi docens, Semmelweis Egyetem, Szemészeti Klinika, Budapest)
  • Anikó SOMOGYI (ny. egyetemi tanár, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Péter SÓTONYI (professor emeritus, Semmelweis Egyetem, Igazságügyi és Biztosítás-orvostani Intézet, Budapest)
  • Péter Jr. SÓTONYI (egyetemi tanár, Semmelweis Egyetem, Városmajori Szív- és Érsebészeti Klinika, Budapest)
  • Ildikó SÜVEGES (professor emeritus, Semmelweis Egyetem, Szemészeti Klinika, Budapest)
  • György SZABÓ (professor emeritus, Semmelweis Egyetem, Arc-Állcsont-Szájsebészeti és Fogászati Klinika, Budapest)
  • Ferenc SZALAY (professor emeritus, Semmelweis Egyetem, Belgyógyászati és Onkológiai Klinika, Budapest)
  • Miklós SZENDRŐI (professor emeritus, Semmelweis Egyetem, Ortopédiai Klinika, Budapest)
  • István SZILVÁSI (egyetemi tanár, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Miklós TÓTH (egyetemi tanár, Semmelweis Egyetem, Belgyógyászati és Onkológiai Klinika, Budapest)
  • László TRINGER (professor emeritus, Semmelweis Egyetem, Pszichiátriai és Pszichoterápiás Klinika, Budapest)
  • Tivadar TULASSAY (professor emeritus, Semmelweis Egyetem, I. Gyermekgyógyászati Klinika, Budapest)
  • Zsolt TULASSAY (professor emeritus, Semmelweis Egyetem, Belgyógyászati és Hematológiai Klinika, Budapest)
  • Lívia VASAS (ny. könyvtárigazgató, Semmelweis Egyetem, Központi Könyvtár, Budapest)
  • Barna VÁSÁRHELYI (egyetemi tanár, Semmelweis Egyetem, Laboratóriumi Medicina Intézet, Budapest)
  • László VÉCSEI (professor emeritus, Szegedi Tudományegyetem, Neurológiai Klinika, Szeged)
  • Gábor WINKLER (egyetemi tanár, Szent János Kórház, Belgyógyászati Osztály, Budapest)

Nemzetközi szerkesztőbizottság - International Editorial Board:

  • Elnök/President Péter SÓTONYI (Budapest)
  • Ernest ADEGHATE (Al Ain)
  • Ferenc ANTONI (Edinburgh)
  • Maciej BANACH (Łódź)
  • Klára BERENCSI (Rosemont)
  • Angelo BIGNAMINI (Milano)
  • Anupam BISHAYEE (Signal Hill)
  • Hubert E. BLUM (Freiburg)
  • G. László BOROS (Los Angeles)
  • Frank A. CHERVENAK (New York)
  • Meinhard CLASSEN (München)
  • József DÉZSY (Wien)
  • Peter ECKL (Salzburg)
  • Péter FERENCI (Wien)
  • Madelaine HAHN (Erlangen)
  • S. Tamás ILLÉS (Bruxelles)
  • Michael KIDD (Toronto)
  • Andrzej KOKOSZKA (Warsaw)
  • Márta KORBONITS (London)
  • Asim KURJAK (Zagreb)
  • Manfred MAIER (Wien)
  • Neil MCINTYRE (London)
  • Lajos OKOLICSÁNYI (Padova)
  • Amado Salvador PENA (Amsterdam)
  • Guliano RAMADORI (Goettingen)
  • Olivér RÁCZ (Košice)
  • Roberto ROMERO (Detroit)
  • Rainer SCHÖFL (Linz)
  • Zvi VERED (Tel Aviv)
  • Josef VESELY (Olomouc)
  • Ákos ZAHÁR (Hamburg)

Akadémiai Kiadó Zrt. 1117 Budapest
Budafoki út 187-189.
A épület, III. emelet
Phone: (+36 1) 464 8235
Email: orvosihetilap@akademiai.hu

2020  
Total Cites 1277
WoS
Journal
Impact Factor
0,540
Rank by Medicine, General & Internal 155/169 (Q4)
Impact Factor  
Impact Factor 0,310
without
Journal Self Cites
5 Year 0,461
Impact Factor
Journal  0,17
Citation Indicator  
Rank by Journal  Medicine, General & Internal 203/313 (Q4)
Citation Indicator   
Citable 261
Items
Total 229
Articles
Total 32
Reviews
Scimago 21
H-index
Scimago 0,176
Journal Rank
Scimago Medicine (miscellaneous) Q4
Quartile Score  
Scopus 921/1187=0,8
Scite Score  
Scopus General Medicine 494/793 (Q3)
Scite Score Rank  
Scopus 0,283
SNIP  
Days from  28
submission  
to acceptance  
Days from  114
acceptance  
to publication  
Acceptance 72%
Rate

2019  
Total Cites
WoS
1 085
Impact Factor 0,497
Impact Factor
without
Journal Self Cites
0,212
5 Year
Impact Factor
0,396
Immediacy
Index
0,126
Citable
Items
247
Total
Articles
176
Total
Reviews
71
Cited
Half-Life
6,1
Citing
Half-Life
7,3
Eigenfactor
Score
0,00071
Article Influence
Score
0,045
% Articles
in
Citable Items
71,26
Normalized
Eigenfactor
0,08759
Average
IF
Percentile
10,606
Scimago
H-index
20
Scimago
Journal Rank
0,176
Scopus
Scite Score
864/1178=0,4
Scopus
Scite Score Rank
General Medicine 267/529 (Q3)
Scopus
SNIP
0,254
Acceptance
Rate
73%

 

Orvosi Hetilap
Publication Model Hybrid
Submission Fee none
Article Processing Charge 900 EUR/article
Printed Color Illustrations 20 EUR (or 5000 HUF) + VAT / piece
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 844 EUR / 1124 USD
Print + online subscription: 956 EUR / 1326 USD
Subscription fee 2022 Online subsscription: 858 EUR / 1157 USD
Print + online subscription: 975 EUR / 1352 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Orvosi Hetilap
Language Hungarian
Size A4
Year of
Foundation
1857
Publication
Programme
2021 Volume 162
Volumes
per Year
1
Issues
per Year
52
Founder Markusovszky Lajos Alapítvány -- Lajos Markusovszky Foundation
Founder's
Address
H-1088 Budapest, Szentkriályi u. 46.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0030-6002 (Print)
ISSN 1788-6120 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2021 15 0 0
Jul 2021 29 0 0
Aug 2021 32 0 0
Sep 2021 20 0 0
Oct 2021 8 0 0
Nov 2021 19 0 0
Dec 2021 1 0 0